Cited by 23Liver Disease Diagnosis and TreatmentLiver Diseases and ImmunityAlcohol Consumption and Health Effects

Targeting MASLD and MASH in the US Hispanic/Latino Population: A Review

Cumpian, Nicholas A., Gutierrez, Julio A., Wu, William, Saab, Sammy·2025·JAMA Internal Medicine

Abstract

Importance: The prevalence of metabolic dysfunction–associated steatotic liver disease (MASLD) in the US is highest among Hispanic/Latino individuals. Their risk of developing metabolic dysfunction–associated steatohepatitis (MASH) with fibrosis, cirrhosis with progression to hepatocellular carcinoma and need for liver transplant, and death is similarly elevated. Observations: The Hispanic/Latino population is the fastest-growing ethnic group in the US, and their annual increase in MASLD prevalence outpaces other ethnic groups. Cardiometabolic and genetic risk factors are highly prevalent among Hispanic/Latino persons and are closely linked to the development of MASLD. Food insecurity, limited access to health care, language barriers, and low health literacy also contribute to the risk of MASLD or progressing to MASH and cirrhosis. Culturally tailored interventions may improve individual outcomes. Screening for chronic and advanced liver disease due to MASLD can be done in high-risk patients using the Fibrosis-4 Index (FIB-4), although several studies suggest current thresholds may be insufficiently sensitive for Hispanic/Latino patients. US Food and Drug Administration–approved liver-directed pharmacologic therapy for MASH should be considered alongside management of cardiometabolic risk factors, as outlined in a proposed pathway incorporating new FIB-4 and secondary assessment thresholds for Hispanic/Latino patients. Conclusions and Relevance: The prevalence of MASLD and MASH among Hispanic/Latino persons in the US is a significant public health challenge. Addressing this issue requires multifaceted, culturally mindful strategies that target disparities in nutrition, physical activity, genetics, research, and social determinants of health. Clinicians should incorporate routine FIB-4 risk stratification for MASLD in Hispanic/Latino patients with cardiometabolic risk factors to enable early detection and intervention.

Integrity signals

Registry

Crossref · 10.1001/jamainternmed.2025.4769

Cites

140 of 140 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cumpian, N. A., Gutierrez, J. A., Wu, W., & Saab, S.
Affiliations
  • University of California, Los Angeles (US)
  • Scripps Clinic (US)
Venue
JAMA Internal Medicine
Published
2025-11-01
Volume
185
Issue
11
Pages
1376
ISSN
2168-6106 (ISSN-L)
OpenAlex
W4414383918
Cited by
22
References
140
Citations by year
2026: 21 · 2025: 1
FWCI
3.39
Type
journal article
Language
en
Open access
closed
Locations
  • JAMA Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Keywords
non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, Hispanic/Latino populations, liver fibrosis, FIB-4, liver disease screening, cardiometabolic risk factors, food insecurity, health disparities, culturally tailored interventions, hepatocellular carcinoma, liver transplantation, social determinants of health
MeSH terms
White, Fatty Liver, Hispanic or Latino, Humans, Risk Factors, United States, Prevalence, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review